Perrigo CEO Resigns; Board Appoints Interim Leadership
Introducing TipRanks MCP for Agents
- Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
- Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.
Perrigo Company ( (PRGO) ) has provided an update.
On June 7, 2026, Perrigo’s President and CEO Patrick Lockwood-Taylor resigned effective immediately from his executive roles and board seat after the board determined that certain personal conduct violated the company’s Code of Conduct and core values, though it was unrelated to business strategy, operations or financial reporting. The board reduced its size from nine to eight directors and appointed board member Albert A. Manzone as interim President and CEO, launched a search for a permanent chief executive, and reaffirmed its full-year 2026 financial outlook, signaling an intent to maintain strategic continuity and reassure investors amid the sudden leadership transition.
The most recent analyst rating on (PRGO) stock is a Buy
with a $17.00 price target.
To see the full list of analyst forecasts on Perrigo Company stock,
see the PRGO Stock Forecast page.
Spark’s Take on PRGO Stock
According to Spark, TipRanks’ AI Analyst, PRGO is a Neutral.
The score is held back primarily by weak financial performance (large TTM losses, declining revenue, and leverage pressure). Offsetting factors include still-positive (though slowing) cash generation, modestly improving near-term technical momentum, and constructive updates from the earnings call and financing actions that support liquidity and debt reduction.
To see Spark’s full report on PRGO stock,
click here.
More about Perrigo Company
Perrigo Company plc, listed on the NYSE under the ticker PRGO, is a leading provider of consumer self-care products and over-the-counter health and wellness solutions. The company focuses on empowering consumers to proactively prevent or treat self-manageable conditions, positioning itself as a significant player in the consumer health and OTC markets.
Average Trading Volume: 3,045,922
Technical Sentiment Signal: Sell
Current Market Cap: $1.5B
See more insights into PRGO stock on TipRanks’ Stock Analysis page.
